The relationship between FDG uptake in PET scans and biological behavior in breast cancer.

Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

BACKGROUND: Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer. MATERIAL AND METHODS: PET studies were performed preoperatively on 37 patients with breast carcinoma. SUVs were counted at one hour (early phase) and at two hours (delayed phase) after FDG injection. The relationships between SUVs and 13 clinical, pathological and immunohistchemical factors were studied. RESULTS: A significant association was found between FDG accumulation and early and delayed phase mitotic counts (p=0.0018 and 0.0010, respectively), Ki67 positive cell percentage (p=0.0098 and 0.0062, respectively), and nuclear grade (p=0.0232 and 0.0195, respectively). On the other hand, nodal status weakly correlated with the delayed phase (p=0.0907). However, other clinicopathological parameters and immunohistopathological status, which included tumor size, age, histology, estrogen receptor, progesterone receptor and Her2/neu overexpression, did not correlate significantly with FDG uptake. CONCLUSION: Mitotic count and Ki67 reflect cellular aggressiveness. These parameters were strongly correlated with tracer uptake. Thus our data suggested that the biological behavior of breast cancer is reflected in the variation of FDG uptake by the tumor. However, whether FDG uptake is a true prognostic and predictive factor remains to be confirmed in larger studies over an extended period of time.

Original languageEnglish
Pages (from-to)260-268
Number of pages9
JournalBreast cancer (Tokyo, Japan)
Volume14
Issue number3
DOIs
Publication statusPublished - 2007
Externally publishedYes

Fingerprint

Deoxyglucose
Positron-Emission Tomography
Breast Neoplasms
Neoplasms
Progesterone Receptors
Estrogen Receptors
Statistical Factor Analysis
Histology
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The relationship between FDG uptake in PET scans and biological behavior in breast cancer. / Shimoda, Wataru; Hayashi, Mitsuhiro; Murakami, Koji; Oyama, Tetsunari; Sunagawa, Masakatsu.

In: Breast cancer (Tokyo, Japan), Vol. 14, No. 3, 2007, p. 260-268.

Research output: Contribution to journalArticle

Shimoda, Wataru ; Hayashi, Mitsuhiro ; Murakami, Koji ; Oyama, Tetsunari ; Sunagawa, Masakatsu. / The relationship between FDG uptake in PET scans and biological behavior in breast cancer. In: Breast cancer (Tokyo, Japan). 2007 ; Vol. 14, No. 3. pp. 260-268.
@article{b4279b0b34354eb4b6cbfb479792eaa1,
title = "The relationship between FDG uptake in PET scans and biological behavior in breast cancer.",
abstract = "BACKGROUND: Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer. MATERIAL AND METHODS: PET studies were performed preoperatively on 37 patients with breast carcinoma. SUVs were counted at one hour (early phase) and at two hours (delayed phase) after FDG injection. The relationships between SUVs and 13 clinical, pathological and immunohistchemical factors were studied. RESULTS: A significant association was found between FDG accumulation and early and delayed phase mitotic counts (p=0.0018 and 0.0010, respectively), Ki67 positive cell percentage (p=0.0098 and 0.0062, respectively), and nuclear grade (p=0.0232 and 0.0195, respectively). On the other hand, nodal status weakly correlated with the delayed phase (p=0.0907). However, other clinicopathological parameters and immunohistopathological status, which included tumor size, age, histology, estrogen receptor, progesterone receptor and Her2/neu overexpression, did not correlate significantly with FDG uptake. CONCLUSION: Mitotic count and Ki67 reflect cellular aggressiveness. These parameters were strongly correlated with tracer uptake. Thus our data suggested that the biological behavior of breast cancer is reflected in the variation of FDG uptake by the tumor. However, whether FDG uptake is a true prognostic and predictive factor remains to be confirmed in larger studies over an extended period of time.",
author = "Wataru Shimoda and Mitsuhiro Hayashi and Koji Murakami and Tetsunari Oyama and Masakatsu Sunagawa",
year = "2007",
doi = "10.2325/jbcs.14.260",
language = "English",
volume = "14",
pages = "260--268",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - The relationship between FDG uptake in PET scans and biological behavior in breast cancer.

AU - Shimoda, Wataru

AU - Hayashi, Mitsuhiro

AU - Murakami, Koji

AU - Oyama, Tetsunari

AU - Sunagawa, Masakatsu

PY - 2007

Y1 - 2007

N2 - BACKGROUND: Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer. MATERIAL AND METHODS: PET studies were performed preoperatively on 37 patients with breast carcinoma. SUVs were counted at one hour (early phase) and at two hours (delayed phase) after FDG injection. The relationships between SUVs and 13 clinical, pathological and immunohistchemical factors were studied. RESULTS: A significant association was found between FDG accumulation and early and delayed phase mitotic counts (p=0.0018 and 0.0010, respectively), Ki67 positive cell percentage (p=0.0098 and 0.0062, respectively), and nuclear grade (p=0.0232 and 0.0195, respectively). On the other hand, nodal status weakly correlated with the delayed phase (p=0.0907). However, other clinicopathological parameters and immunohistopathological status, which included tumor size, age, histology, estrogen receptor, progesterone receptor and Her2/neu overexpression, did not correlate significantly with FDG uptake. CONCLUSION: Mitotic count and Ki67 reflect cellular aggressiveness. These parameters were strongly correlated with tracer uptake. Thus our data suggested that the biological behavior of breast cancer is reflected in the variation of FDG uptake by the tumor. However, whether FDG uptake is a true prognostic and predictive factor remains to be confirmed in larger studies over an extended period of time.

AB - BACKGROUND: Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer. MATERIAL AND METHODS: PET studies were performed preoperatively on 37 patients with breast carcinoma. SUVs were counted at one hour (early phase) and at two hours (delayed phase) after FDG injection. The relationships between SUVs and 13 clinical, pathological and immunohistchemical factors were studied. RESULTS: A significant association was found between FDG accumulation and early and delayed phase mitotic counts (p=0.0018 and 0.0010, respectively), Ki67 positive cell percentage (p=0.0098 and 0.0062, respectively), and nuclear grade (p=0.0232 and 0.0195, respectively). On the other hand, nodal status weakly correlated with the delayed phase (p=0.0907). However, other clinicopathological parameters and immunohistopathological status, which included tumor size, age, histology, estrogen receptor, progesterone receptor and Her2/neu overexpression, did not correlate significantly with FDG uptake. CONCLUSION: Mitotic count and Ki67 reflect cellular aggressiveness. These parameters were strongly correlated with tracer uptake. Thus our data suggested that the biological behavior of breast cancer is reflected in the variation of FDG uptake by the tumor. However, whether FDG uptake is a true prognostic and predictive factor remains to be confirmed in larger studies over an extended period of time.

UR - http://www.scopus.com/inward/record.url?scp=38449090716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449090716&partnerID=8YFLogxK

U2 - 10.2325/jbcs.14.260

DO - 10.2325/jbcs.14.260

M3 - Article

VL - 14

SP - 260

EP - 268

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 3

ER -